Mr David Sweetnam Consultant Knee Surgeon

Mr David Sweetnam is a Consultant Orthopaedic Surgeon in London specialising exclusively in knee conditions. He has more than 30 years of NHS experience, including over 20 years as a Consultant and 10 years as Clinical Lead in a busy orthopaedic and trauma department.

Having qualified from University College London in 1987, where he was awarded the Fitton Prize in Orthopaedic Surgery, Mr Sweetnam completed specialist orthopaedic training on the Royal National Orthopaedic Hospital Registrar Training Scheme. He gained his specialist qualification in 1995 and subsequently undertook a specialist knee fellowship in Australia, focusing on joint replacement surgery and sports injuries.

Mr Sweetnam was appointed Consultant Orthopaedic Surgeon at The Whittington Hospital in 1998, where he worked for over two decades before focusing solely on private practice in 2018. He treats the full spectrum of knee problems, from sports injuries and meniscal tears to ligament injuries, cartilage damage, knee arthritis and knee replacement.

He is committed to careful, individualised decision-making and strongly believes that surgery should be undertaken only when it offers a clear benefit. Many patients can be treated successfully without an operation, through accurate diagnosis, rehabilitation, physiotherapy and other conservative measures. When surgery is required, he offers extensive experience in arthroscopic knee surgery, ACL reconstruction, cartilage procedures and partial or total knee replacement.

Mr Sweetnam treats a broad range of patients, including professional and elite athletes, senior figures in business, media and public life, and military personnel. He has chaired The Future of Football Medicine at Camp Nou in Barcelona, organised in association with FIFA and supported by FC Barcelona, and serves in a surgical advisory role to the wider INEOS sports portfolio.

Alongside his clinical work, Mr Sweetnam founded and chairs the INEOS Oxford Institute at the University of Oxford, supporting research into antimicrobial resistance and novel drug discovery. He is a Patron of the Royal College of Surgeons and a member of the Guild of Benefactors of the University of Cambridge.